Vetter, Microdermics ink deal to develop novel microneedle drug delivery system

Prefilled drug delivery system developer Vetter and medical device maker Microdermics said yesterday that the companies are working to develop a novel microneedle drug delivery system.

Microdermics has developed a low-cost, commercially scalable, customizable microneedle platform that delivers vaccines and biologics. The company said it expects its intradermal delivery system will enter Phase I clinical trials this year.

Get the full story at our sister site, Drug Delivery Business News.

The post Vetter, Microdermics ink deal to develop novel microneedle drug delivery system appeared first on MassDevice.

from MassDevice http://ift.tt/2reUSNu